Evidence map›Paper›PMID 37558962›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Viral Vector-Induced Ocular Hypertension in Mice.

J Cameron Millar, Yogapriya Sundaresan, Gulab S Zode, Abbot F Clark

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J Cameron MillarDepartment of Pharmacology & Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
Yogapriya SundaresanDepartment of Pharmacology & Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
Gulab S ZodeDepartment of Pharmacology & Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.
Abbot F ClarkDepartment of Pharmacology & Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA. abe.clark@unthsc.edu.
University of North Texas · USUniversity of North Texas Health Science Center · US

Funding

Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of GlaucomaR01EY026177 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ZODE, GULAB · 2016 to 2025
$3.8M
Glucocorticoids, ocular hypertension and glaucomaR01EY030967 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI CLARK, ABBOT FREDERICK, GEISERT, ELDON E · 2020 to 2024
$2.8M
Novel Genome Editing for the Treatment of GlaucomaR01EY030366 · NEI · UNIVERSITY OF IOWA · PI CLARK, ABBOT FREDERICK, SHEFFIELD, VAL C. · 2019 to 2023
$2.7M
Novel Glaucoma Treatment Using Genome EditingR01EY024259 · NEI · UNIVERSITY OF IOWA · PI CLARK, ABBOT FREDERICK, SHEFFIELD, VAL C. · 2014 to 2018
$2.6M
What Determines Thalamic Spatio-Temporal Properties?R01EY016224 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KAPLAN, EHUD · 2006 to 2010
$2.3M
Impaired TRVP4-eNOS signaling in TM contributes to glaucomaR01EY034238 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI Swapnil K. Sonkusare, Gulab Zode · 2022 to 2026
$2.2M
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAGR01EY028616 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ZODE, GULAB · 2018 to 2021
$1.4M
Development and characterization of an inducible model for myocilin POAGR21EY034333 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI ZODE, GULAB · 2023 to 2024
$432k
A New Model of Human Primary Open-Angle GlaucomaR21EY019977 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI CLARK, ABBOT FREDERICK · 2010 to 2011
$392k
NEI NIH HHS R01 EY016224NEI NIH HHS R01 EY024259NEI NIH HHS R01 EY028616NEI NIH HHS R01 EY030366NEI NIH HHS R01 EY030967NEI NIH HHS R21 EY019977NEI NIH HHS R21 EY034333
6 · The paper itself

Abstract

Viral transduction of the mouse trabecular meshwork using a variety of transgenes associated with glaucoma generates an inducible and reproducible method for generating ocular hypertension due to increased aqueous humor outflow resistance of the conventional outflow pathway. Both adenovirus serotype 5 (Ad5) and lentiviruses have selective tropism for the mouse trabecular meshwork with intraocular injections. Accurate intraocular pressures are easily measured using a rebound tonometer, and aqueous humor outflow facilities can be measured in anesthetized live mice.

Indexed as

GlaucomaOcular HypertensionAnimalsAqueous HumorIntraocular PressureMiceTrabecular MeshworkGlaucomaIntraocular pressureMouse modelsViral transducing vectors

Identifiers

PMID37558962
OpenAlexW4385712147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.